Istituto Nazionale per la Ricerca sul Cancro -IST

Genoa 16132

0 studies enrolling now · 3 studies all time

What they study most

Hormone Refractory Prostate Cancer, Prostate Cancer, Prostatic Neoplasms

Studies at this site

• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed